Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)

2.2 / 5 stars · 48/110 Roast Me

BRISTOL-MYERS SQUIBB COMPANY Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)

BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnSaleOfSecuritiesNet · last filed 2018-10-25

  • BRISTOL-MYERS SQUIBB COMPANY gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $0.00.
Period endGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 3 monthGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 6 monthGain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month
2018-09-30$0.00
10-Q · filed 2018-10-25
$0.00
derived: sum of 2 quarters · filed 2018-10-25
$0.00
10-Q · filed 2018-10-25
2018-06-30$0.00
10-Q · filed 2018-07-26
$0.00
10-Q · filed 2018-07-26
2018-03-31$0.00
10-Q · filed 2018-04-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64